Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
NMR vs GS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
NMR vs GS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $23.56B | $291.19B |
| Revenue (TTM) | $4.76T | $126.85B |
| Net Income (TTM) | $370.05B | $16.67B |
| Gross Margin | 45.6% | 41.1% |
| Operating Margin | 11.3% | 14.5% |
| Forward P/E | 10.0x | 15.8x |
| Total Debt | $17.30T | $616.93B |
| Cash & Equiv. | $4.30T | $182.09B |
NMR vs GS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nomura Holdings, In… (NMR) | 100 | 191.5 | +91.5% |
| The Goldman Sachs G… (GS) | 100 | 477.0 | +377.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NMR vs GS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NMR is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 1.32, yield 4.6%
- Lower volatility, beta 1.32, current ratio 1.43x
- PEG 0.51 vs GS's 1.13
GS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 17.0%, EPS growth 77.3%
- 5.4% 10Y total return vs NMR's 146.3%
- 17.0% NII/revenue growth vs NMR's 5.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.0% NII/revenue growth vs NMR's 5.6% | |
| Value | Lower P/E (10.0x vs 15.8x), PEG 0.51 vs 1.13 | |
| Quality / Margins | Efficiency ratio 0.3% vs NMR's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 1.32 vs GS's 1.47, lower leverage | |
| Dividends | 4.6% yield, 3-year raise streak, vs GS's 1.4% | |
| Momentum (1Y) | +73.4% vs NMR's +51.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NMR's 0.3% |
NMR vs GS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NMR vs GS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GS leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NMR is the larger business by revenue, generating $4.76T annually — 37.5x GS's $126.9B. Profitability is closely matched — net margins range from 11.3% (GS) to 7.6% (NMR).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.76T | $126.9B |
| EBITDAEarnings before interest/tax | $533.0B | $23.4B |
| Net IncomeAfter-tax profit | $370.1B | $16.7B |
| Free Cash FlowCash after capex | $0 | $15.8B |
| Gross MarginGross profit ÷ Revenue | +45.6% | +41.1% |
| Operating MarginEBIT ÷ Revenue | +11.3% | +14.5% |
| Net MarginNet income ÷ Revenue | +7.6% | +11.3% |
| FCF MarginFCF ÷ Revenue | -25.2% | -12.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -5.5% | +45.8% |
Valuation Metrics
NMR leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 10.7x trailing earnings, NMR trades at a 54% valuation discount to GS's 23.1x P/E. Adjusting for growth (PEG ratio), NMR offers better value at 0.55x vs GS's 1.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $23.6B | $291.2B |
| Enterprise ValueMkt cap + debt − cash | $106.8B | $726.0B |
| Trailing P/EPrice ÷ TTM EPS | 10.71x | 23.12x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.99x | 15.84x |
| PEG RatioP/E ÷ EPS growth rate | 0.55x | 1.65x |
| EV / EBITDAEnterprise value multiple | 27.43x | 34.92x |
| Price / SalesMarket cap ÷ Revenue | 0.77x | 2.30x |
| Price / BookPrice ÷ Book value/share | 1.01x | 2.56x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
GS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
GS delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $10 for NMR. NMR carries lower financial leverage with a 4.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), NMR scores 5/9 vs GS's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +10.2% | +12.6% |
| ROA (TTM)Return on assets | +0.6% | +0.9% |
| ROICReturn on invested capital | +1.4% | +1.9% |
| ROCEReturn on capital employed | +2.4% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 4.49x | 5.06x |
| Net DebtTotal debt minus cash | $13.00T | $434.8B |
| Cash & Equiv.Liquid assets | $4.30T | $182.1B |
| Total DebtShort + long-term debt | $17.30T | $616.9B |
| Interest CoverageEBIT ÷ Interest expense | 0.20x | 0.31x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $27,109 today (with dividends reinvested), compared to $16,867 for NMR. Over the past 12 months, GS leads with a +73.4% total return vs NMR's +51.0%. The 3-year compound annual growth rate (CAGR) favors GS at 44.0% vs NMR's 36.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -3.4% | +3.0% |
| 1-Year ReturnPast 12 months | +51.0% | +73.4% |
| 3-Year ReturnCumulative with dividends | +152.1% | +198.7% |
| 5-Year ReturnCumulative with dividends | +68.7% | +171.1% |
| 10-Year ReturnCumulative with dividends | +146.3% | +536.1% |
| CAGR (3Y)Annualised 3-year return | +36.1% | +44.0% |
Risk & Volatility
Evenly matched — NMR and GS each lead in 1 of 2 comparable metrics.
Risk & Volatility
NMR is the less volatile stock with a 1.32 beta — it tends to amplify market swings less than GS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 95.2% from its 52-week high vs NMR's 85.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.32x | 1.47x |
| 52-Week HighHighest price in past year | $9.58 | $984.70 |
| 52-Week LowLowest price in past year | $5.48 | $547.06 |
| % of 52W HighCurrent price vs 52-week peak | +85.2% | +95.2% |
| RSI (14)Momentum oscillator 0–100 | 44.4 | 55.0 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 2.0M |
Analyst Outlook
Evenly matched — NMR and GS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates NMR as "Hold" and GS as "Hold". Consensus price targets imply 6.2% upside for GS (target: $996) vs -29.0% for NMR (target: $6). For income investors, NMR offers the higher dividend yield at 4.63% vs GS's 1.44%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $5.79 | $995.89 |
| # AnalystsCovering analysts | 9 | 55 |
| Dividend YieldAnnual dividend ÷ price | +4.6% | +1.4% |
| Dividend StreakConsecutive years of raises | 3 | 12 |
| Dividend / ShareAnnual DPS | $59.06 | $13.48 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | +3.5% |
GS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NMR leads in 1 (Valuation Metrics). 2 tied.
NMR vs GS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NMR or GS a better buy right now?
For growth investors, The Goldman Sachs Group, Inc.
(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus 5. 6% for Nomura Holdings, Inc. (NMR). Nomura Holdings, Inc. (NMR) offers the better valuation at 10. 7x trailing P/E (10. 0x forward), making it the more compelling value choice. Analysts rate Nomura Holdings, Inc. (NMR) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NMR or GS?
On trailing P/E, Nomura Holdings, Inc.
(NMR) is the cheapest at 10. 7x versus The Goldman Sachs Group, Inc. at 23. 1x. On forward P/E, Nomura Holdings, Inc. is actually cheaper at 10. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nomura Holdings, Inc. wins at 0. 51x versus The Goldman Sachs Group, Inc. 's 1. 13x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NMR or GS?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +171. 1%, compared to +68. 7% for Nomura Holdings, Inc. (NMR). Over 10 years, the gap is even starker: GS returned +536. 1% versus NMR's +146. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NMR or GS?
By beta (market sensitivity over 5 years), Nomura Holdings, Inc.
(NMR) is the lower-risk stock at 1. 32β versus The Goldman Sachs Group, Inc. 's 1. 47β — meaning GS is approximately 11% more volatile than NMR relative to the S&P 500. On balance sheet safety, Nomura Holdings, Inc. (NMR) carries a lower debt/equity ratio of 4% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NMR or GS?
By revenue growth (latest reported year), The Goldman Sachs Group, Inc.
(GS) is pulling ahead at 17. 0% versus 5. 6% for Nomura Holdings, Inc. (NMR). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 7. 2% for Nomura Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NMR or GS?
The Goldman Sachs Group, Inc.
(GS) is the more profitable company, earning 11. 3% net margin versus 7. 6% for Nomura Holdings, Inc. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GS leads at 14. 5% versus 11. 3% for NMR. At the gross margin level — before operating expenses — NMR leads at 45. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NMR or GS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Nomura Holdings, Inc. (NMR) is the more undervalued stock at a PEG of 0. 51x versus The Goldman Sachs Group, Inc. 's 1. 13x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nomura Holdings, Inc. (NMR) trades at 10. 0x forward P/E versus 15. 8x for The Goldman Sachs Group, Inc. — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GS: 6. 2% to $995. 89.
08Which pays a better dividend — NMR or GS?
All stocks in this comparison pay dividends.
Nomura Holdings, Inc. (NMR) offers the highest yield at 4. 6%, versus 1. 4% for The Goldman Sachs Group, Inc. (GS).
09Is NMR or GS better for a retirement portfolio?
For long-horizon retirement investors, The Goldman Sachs Group, Inc.
(GS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 4% yield, +536. 1% 10Y return). Both have compounded well over 10 years (GS: +536. 1%, NMR: +146. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NMR and GS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NMR is a mid-cap deep-value stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.